AACC Names Mark J. Golden as Next CEO
The American Association for Clinical Chemistry (AACC), a global scientific and medical professional organization dedicated to bettering health through laboratory medicine, has announced the appointment of Mark J. Golden as its next CEO effective August 17. As CEO Golden will lead the association as it implements a new strategic plan designed to ensure that the AACC continues to meet the needs of its membership base. "Following an extensive search that considered many qualified candidates, it is with great excitement that AACC's Board of Directors announces Mark Golden's appointment as CEO," said AACC President Dr. Carmen Wiley. "AACC has undergone tremendous changes over the last several years as we have sought out new and innovative ways to help our members do what they do best and provide vital insight, so patients get the care they need. As we enter a new stage of growth with this ambitious strategic plan, we are confident that Mark's leadership skills and experience with professional associations make him the ideal choice to serve as AACC's CEO and to guide us forward." Golden most recently served for seven years as the Executive Director and CEO of the National Society of Professional Engineers (NSPE). At the NSPE, Golden helped redesign the society's membership, business model and also rebranded the association. Before his time at the NSPE Golden served in senior roles at the National Court Reporters Association, the Personal Communications Industry Association, and the Association of Telemessaging Services International. "It is a privilege to be chosen as AACC's CEO," said Golden, "and I am excited to advance the association's mission to provide lab professionals with the resources they need to continue to adapt to the rapidly changing healthcare environment and solve challenging patient care problems. I look forward to working with the AACC Board of Directors and staff to shape the association's current programs and to launch new initiatives with a focus on advocacy, scientific advancement, the value of lab professionals, data analytics, and expanding our community. Together, we will improve patient outcomes by advancing lab testing and diagnosis."